Diagnosis and management of Aspergillus diseases: executive summary of the 2017 ESCMID-ECMM-ERS guideline, Clin Microbiol Infect, 2018. ,
URL : https://hal.archives-ouvertes.fr/hal-01953645
Successful treatment of invasive mucormycosis with isavuconazole in pediatric patients. Pediatr Blood Cancer, 2018. ,
Isavuconazole in a successful combination treatment of disseminated mucormycosis in a child with acute lymphoblastic leukaemia and generalized haemochromatosis: a case report and review of the literature, Mycopathologia, 2018. ,
ECIL-6 guidelines for the treatment of invasive candidiasis, aspergillosis and mucormycosis in leukemia and hematopoietic stem cell transplant patients ,
ECIL-4): guidelines for diagnosis, prevention, and treatment of invasive fungal diseases in paediatric patients with cancer or allogeneic haemopoietic stem-cell transplantation, Fourth European conference on infections in Leukaemia, 2014. ,
Isavuconazole treatment for mucormycosis: a single-arm open-label trial and case-control analysis, Lancet Infect Dis, issue.16, pp.71-73, 2016. ,
Isavuconazole versus voriconazole for primary treatment of invasive mould disease caused by Aspergillus and other filamentous fungi (SECURE): a phase 3, randomisedcontrolled, non-inferiority trial, Lancet, issue.15, pp.1159-1168, 2016. ,
Increasing incidence of zygomycosis (mucormycosis), France, 1997-2006. Emerg Infect Dis, 2009. ,
Zygomycosis in Europe: analysis of 230 cases accrued by the registry of the European Confederation of Medical Mycology (ECMM) working group on Zygomycosis between, 2005. ,
, Clin Microbiol Infect, 2011.
Epidemiology of mucormycosis in Europe, Clin Microbiol Infect, 2014. ,
A global analysis of mucormycosis in France: the RetroZygo study, Clin Infect Dis, 2005. ,
URL : https://hal.archives-ouvertes.fr/hal-00818503
ESCMID and ECMM joint clinical guidelines for the diagnosis and management of mucormycosis 2013, Clin Microbiol Infect, 2014. ,
Collaborators of Zygomyco.net and/or FungiScope R. Invasive mucormycosis in children: an epidemiologic study in European and non-European countries based on two registries, BMC Infect Dis, 2016. ,
Prospective pilot study of high-dose (10 mg/kg/day) liposomal amphotericin B (L-AMB) for the initial treatment of mucormycosis, J Antimicrob Chemother, 2015. ,
URL : https://hal.archives-ouvertes.fr/hal-02317920
Tissue penetration of antifungal agents, Clin Microbiol Rev, 2014. ,
Therapeutic drug monitoring of posaconazole oral suspension in paediatric patients younger than 13 years of age: a retrospective analysis and literature review, J Clin Pharm Ther, 2016. ,
New pharmacological opportunities for the treatment of invasive mould diseases, J Antimicrob Chemother, 2017. ,
Infect Dis Clin N Am, 2016. ,